Human Experimentation

• 

  Subject Areas on Research

  • 'What do they know about it?' How the North Carolina public views cancer clinical trials: implications for primary care doctors. 
  • ACCF/AHA consensus conference report on professionalism and ethics. 
  • Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. 
  • Bioethics and public policy: still seeking a forum. 
  • Challenges faced by research ethics committees in El Salvador: results from a focus group study. 
  • Clinical research. 
  • Clinical trials and medical care: defining the therapeutic misconception. 
  • Conducting empirical research on informed consent: challenges and questions. 
  • Confidentiality: more than a linkage file and a locked drawer. 
  • Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. 
  • Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. 
  • Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. 
  • Establishment of ethical oversight of human research in El Salvador: lessons learned. 
  • Ethical concerns of nursing reviewers: an international survey. 
  • Ethical considerations in human subjects research. 
  • Ethics. Fair benefits for research in developing countries. 
  • Far beyond informed consent. US research institutions keep close watch on OPRR's suspensions. 
  • Finding a forum for bioethics in U.S. public policy. 
  • Heterogeneous but "standard" coding systems for adverse events: Issues in achieving interoperability between apples and oranges. 
  • History Lesson: Vaccine Trials in the Classroom. 
  • How can we draw the line between clinical care and medical research. 
  • How proxies make decisions about research for patients with Alzheimer's disease. 
  • Impediments to clinical research in the United States. 
  • Incentives for children in research. 
  • Informed consent and investigational new drug abuses in the U.S. military. 
  • Informed consent for research in Borderline Personality Disorder. 
  • Issues affecting minority participation in research studies of Alzheimer disease. 
  • Judging the past. The case of the human radiation experiments. 
  • Lessons learned from a clinical trial. 
  • Misplaced flexibility: revise policies but cling to principles. 
  • Models to study ancient host-pathogen interactions: lessons from Crete. 
  • Oversight mechanisms for clinical research. 
  • Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. 
  • Privacy, families, and human subject protections: some lessons from pedigree research. 
  • Protecting Behavioral Health Research Participants in the ED Setting: Issues of Consent. 
  • Protecting the vulnerable in brain research. 
  • Quality improvement and evidence-based practice change projects and the institutional review board: is approval necessary? 
  • Regarding Mohan, Kuplian, and Willoughby, IJROBP 2000;46:575-580. 
  • Reproductive health care policies around the world. On basic and clinical research within the human assisted reproduction setting. 
  • Restoring balance: a consensus statement on the protection of vulnerable research participants. 
  • Special care unit research: ethical issues. 
  • The Legal Ethics of Pediatric Research 
  • The Tuskegee Legacy Project: history, preliminary scientific findings, and unanticipated societal benefits. 
  • The controversy over retrospective moral judgment. 
  • The ethics of experimenting with human brain tissue. 
  • The role of local institutional review boards in protecting human research subjects. 
  • Toward protecting the safety of participants in clinical trials. 
  • Urge overkill: protecting deidentified human subjects at what price? 
  • Use of altered informed consent in pragmatic clinical research. 
  • Who will enroll? Predicting participation in a phase II AIDS vaccine trial. 
  • gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas. 
• 

  Keywords of People

  • Barfield, Raymond Carlton, Professor of Pediatrics, Duke Science & Society
  • Ferrari, Guido, Associate Professor of Surgery, Molecular Genetics and Microbiology
  • Richesson, Rachel L, Associate Professor in the School of Nursing, School of Nursing